2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide

C99H111Br2N11O18Si2 — CID 157230109

IUPAC2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide
SMILESCOC(C(=O)O)c1cccc(Br)c1.COc1ccccc1-c1[nH]nc2ncc(-c3cccc(C(OC)C(=O)N(C)C)c3)cc12.COc1ccccc1-c1nn(COCC[Si](C)(C)C)c2ncc(-c3cccc(C(OC)C(=O)N(C)C)c3)cc12.COc1ccccc1-c1nn(COCC[Si](C)(C)C)c2ncc(-c3cccc(C(OC)C(=O)O)c3)cc12.O=C(O)C(O)c1cccc(Br)c1
InChIInChI=1S/C30H38N4O4Si.C28H33N3O5Si.C24H24N4O3.C9H9BrO3.C8H7BrO3/c1-33(2)30(35)28(37-4)22-12-10-11-21(17-22)23-18-25-27(24-13-8-9-14-26(24)36-3)32-34(29(25)31-19-23)20-38-15-16-39(5,6)7;1-34-24-12-7-6-11-22(24)25-23-16-21(19-9-8-10-20(15-19)26(35-2)28(32)33)17-29-27(23)31(30-25)18-36-13-14-37(3,4)5;1-28(2)24(29)22(31-4)16-9-7-8-15(12-16)17-13-19-21(26-27-23(19)25-14-17)18-10-5-6-11-20(18)30-3;1-13-8(9(11)12)6-3-2-4-7(10)5-6;9-6-3-1-2-5(4-6)7(10)8(11)12/h8-14,17-19,28H,15-16,20H2,1-7H3;6-12,15-17,26H,13-14,18H2,1-5H3,(H,32,33);5-14,22H,1-4H3,(H,25,26,27);2-5,8H,1H3,(H,11,12);1-4,7,10H,(H,11,12)
InChIKeyATZRNRYPHITUDB-UHFFFAOYSA-N
MW1959.02 g/mol
LogP19.58
Rot. Bonds33

About 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide

2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide (PubChem CID 157230109) has the molecular formula C99H111Br2N11O18Si2 and a molecular weight of 1959.02 g/mol. Its IUPAC name is 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide.

Molecular Properties

Compound Name2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide
PubChem CID157230109
Molecular FormulaC99H111Br2N11O18Si2
Molecular Weight1959.02 g/mol
Exact Mass1955.60
IUPAC Name2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide
SMILESCOC(C(=O)O)c1cccc(Br)c1.COc1ccccc1-c1[nH]nc2ncc(-c3cccc(C(OC)C(=O)N(C)C)c3)cc12.COc1ccccc1-c1nn(COCC[Si](C)(C)C)c2ncc(-c3cccc(C(OC)C(=O)N(C)C)c3)cc12.COc1ccccc1-c1nn(COCC[Si](C)(C)C)c2ncc(-c3cccc(C(OC)C(=O)O)c3)cc12.O=C(O)C(O)c1cccc(Br)c1
InChIInChI=1S/C30H38N4O4Si.C28H33N3O5Si.C24H24N4O3.C9H9BrO3.C8H7BrO3/c1-33(2)30(35)28(37-4)22-12-10-11-21(17-22)23-18-25-27(24-13-8-9-14-26(24)36-3)32-34(29(25)31-19-23)20-38-15-16-39(5,6)7;1-34-24-12-7-6-11-22(24)25-23-16-21(19-9-8-10-20(15-19)26(35-2)28(32)33)17-29-27(23)31(30-25)18-36-13-14-37(3,4)5;1-28(2)24(29)22(31-4)16-9-7-8-15(12-16)17-13-19-21(26-27-23(19)25-14-17)18-10-5-6-11-20(18)30-3;1-13-8(9(11)12)6-3-2-4-7(10)5-6;9-6-3-1-2-5(4-6)7(10)8(11)12/h8-14,17-19,28H,15-16,20H2,1-7H3;6-12,15-17,26H,13-14,18H2,1-5H3,(H,32,33);5-14,22H,1-4H3,(H,25,26,27);2-5,8H,1H3,(H,11,12);1-4,7,10H,(H,11,12)
InChIKeyATZRNRYPHITUDB-UHFFFAOYSA-N
XLogP19.58
TPSA358.81 Ų
H-Bond Donors5
H-Bond Acceptors23
Rotatable Bonds33
Heavy Atoms132
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001959.02
LogP ≤ 519.58
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide?
The IUPAC name of 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide (CID 157230109) is 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide.
What is the SMILES notation for 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide?
The canonical SMILES for 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide is COC(C(=O)O)c1cccc(Br)c1.COc1ccccc1-c1[nH]nc2ncc(-c3cccc(C(OC)C(=O)N(C)C)c3)cc12.COc1ccccc1-c1nn(COCC[Si](C)(C)C)c2ncc(-c3cccc(C(OC)C(=O)N(C)C)c3)cc12.COc1ccccc1-c1nn(COCC[Si](C)(C)C)c2ncc(-c3cccc(C(OC)C(=O)O)c3)cc12.O=C(O)C(O)c1cccc(Br)c1.
What is the InChIKey of 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide?
The InChIKey is ATZRNRYPHITUDB-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H38N4O4Si.C28H33N3O5Si.C24H24N4O3.C9H9BrO3.C8H7BrO3/c1-33(2)30(35)28(37-4)22-12-10-11-21(17-22)23-18-25-27(24-13-8-9-14-26(24)36-3)32-34(29(25)31-19-23)20-38-15-16-39(5,6)7;1-34-24-12-7-6-11-22(24)25-23-16-21(19-9-8-10-20(15-19)26(35-2)28(32)33)17-29-27(23)31(30-25)18-36-13-14-37(3,4)5;1-28(2)24(29)22(31-4)16-9-7-8-15(12-16)17-13-19-21(26-27-23(19)25-14-17)18-10-5-6-11-20(18)30-3;1-13-8(9(11)12)6-3-2-4-7(10)5-6;9-6-3-1-2-5(4-6)7(10)8(11)12/h8-14,17-19,28H,15-16,20H2,1-7H3;6-12,15-17,26H,13-14,18H2,1-5H3,(H,32,33);5-14,22H,1-4H3,(H,25,26,27);2-5,8H,1H3,(H,11,12);1-4,7,10H,(H,11,12).
What are the key properties of 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide?
2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide has a molecular weight of 1959.02 g/mol, XLogP of 19.58, 33 rotatable bonds, 5 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(3-bromophenyl)-2-hydroxyacetic acid;2-(3-bromophenyl)-2-methoxyacetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]acetic acid;2-methoxy-2-[3-[3-(2-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)pyrazolo[5,4-b]pyridin-5-yl]phenyl]-N,N-dimethylacetamide is sourced from PubChem (CID 157230109), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).